300+ investors in your industry, stage, and region Get
Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
CleanTech
Oil and Gas
Film
Retail
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
Social Network
Blockchain
B2B
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Software
Renewable Energy
Crowdfunding
Recruiting
Web3
Medical
Theatre
Venture Capital
Social
Infrastructure
Beauty
Fashion
Climate
LGBT
Cannabis
Celebrity
Life Science
Food and Beverage
Publishing
Mobile Apps
Wine and Spirits
Music
Art
Real Estate
Manufacturing
Sporting Goods
Social Media
Financial Services
FinTech
Franchise
Non Profit
Finance
Internet
Mobile Advertising
Android
Proptech
Digital Media
Impact
Sustainability
Hardware
Enterprise
Biotech
Transportation
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Brazil
LATAM
Oman
Puerto Rico
Poland
Cameroon
Guernsey
Colombia
China
Armenia
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Morocco
Australia
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Paraguay
Seychelles
Botswana
South Africa
Canada
Ireland
France
Denmark
Georgia
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
India
Germany
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Europe
Qatar
Angola
Cyprus
Argentina
Bangladesh
Barbados
Belgium
Jordan
Ethiopia
Austria
Azerbaijan
Bulgaria
Ecuador
Faroe Islands
Jersey
Bahrain
Estonia
Bahamas
Bolivia
Belize
Algeria
Italy
Belarus
Finland
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Liechtenstein
Cambodia
Lebanon
Peru
Mongolia
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 50 Biotech VC Funds & Investors in Ireland (October 2026)

The most active venture capital funds investing in Ireland Biotech startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in Ireland Biotech startup companies. Find investors to raise a Seed, Series A or Series B round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Enterprise Ireland
VC Fund
47 Ireland, United States, United Kingdom Seed, Venture - Series Unknown, Grant Software, Health Care, Information Technology $16k–$8.3M
SOSV
VC Fund
19 United States, India, United Kingdom Seed, Convertible Note, Pre-Seed Biotechnology, Health Care, Software
Western Development Commission
VC Fund
14 Ireland, United States Seed, Venture - Series Unknown, Series A Health Care, Medical Device, Biotechnology $702k–$17M
Kernel Capital
VC Fund
9 Ireland, United Kingdom, France Seed, Venture - Series Unknown Software, Information Technology, Health Care $531k–$12M
Irrus Investments
VC Fund
8 Ireland, Sweden, United States Seed, Venture - Series Unknown, Series A Health Care, Medical Device, Biotechnology $713k–$24M
Atlantic Bridge
VC Fund
7 United States, Ireland, United Kingdom Series A, Series B, Seed Software, Artificial Intelligence, Information Technology $1.1M–$62M
Fountain Healthcare Partners
VC Fund
7 Ireland, United States, France Series A, Series B, Series C Health Care, Biotechnology, Medical $3.3M–$110M
Seroba Life Sciences
VC Fund
6 Ireland, United States, United Kingdom Series A, Series B Health Care, Biotechnology, Medical $4.6M–$105M
AIB Seed Capital Fund
VC Fund
6 Ireland, United States, Jersey Seed, Series A Software, Health Care, Medical $549k–$8.1M
HBAN
VC Fund
6 Ireland, United Kingdom, United States Seed, Venture - Series Unknown Health Care, Software, Medical Device $375k–$7.3M
European Investment Bank
VC Fund
5 France, Germany, Spain Debt Financing, Post-IPO Debt, Venture - Series Unknown Biotechnology, Energy, Health Care $8.7M–$587M
Faber
VC Fund
5 Portugal, Germany, United Kingdom Seed, Pre-Seed, Series A Software, Artificial Intelligence, SaaS $121k–$25M
Elkstone Capital Partners
VC Fund
5 Ireland, United Kingdom, United States Seed, Series A, Venture - Series Unknown Software, Artificial Intelligence, Health Care $797k–$18M
Boole Investment Syndicate
VC Fund
4 Ireland, Estonia, United States Seed, Series A Biotechnology, SaaS, Software $623k–$2.2M
Atlantic Bridge University Fund
VC Fund
4 Ireland, United States Seed, Series A, Series B Health Care, Medical Device, Big Data $859k–$80M
HBAN Medtech Syndicate
VC Fund
4 Ireland Seed, Series B Medical Device, Medical, Health Care $1.3M–$11M
SciFounders
VC Fund
3 United States, Ireland, United Kingdom Seed, Pre-Seed, Series A Health Care, Biotechnology, Medical $400k–$21M
The Yield Lab Europe
VC Fund
3 Ireland, France, United Kingdom Seed, Series A, Venture - Series Unknown AgTech, Agriculture, Biotechnology $605k–$10M
ARCH Venture Partners
VC Fund
3 United States, China, United Kingdom Series A, Series B, Series C Biotechnology, Health Care, Therapeutics $9.1M–$230M
HealthCap
VC Fund
3 United States, Sweden, France Series B, Series A Biotechnology, Health Care, Medical $6M–$92M
Google Ventures
VC Fund
3 United States, United Kingdom, Israel Series A, Series B, Seed Software, Health Care, Biotechnology $1.1M–$121M
Furthr VC
VC Fund
3 Ireland Seed, Venture - Series Unknown Software, Medical Device, Medical $753k–$17M
Act Venture Capital
VC Fund
3 Ireland, United States, United Kingdom Seed, Series A Software, Artificial Intelligence, Information Technology $1M–$13M
Diagnostics Polymers
VC Fund
3 Ireland Convertible Note, Venture - Series Unknown Medical, Big Data, Health Care $1.2M–$1.9M
Pareto Holdings
VC Fund
2 United States, United Kingdom, France Seed, Pre-Seed, Series A Software, Artificial Intelligence, FinTech $125k–$35M
Gaingels
VC Fund
2 United States, Canada, United Kingdom Seed, Series A, Venture - Series Unknown Software, Artificial Intelligence, Health Care $69k–$35M
Novartis Venture Fund
VC Fund
2 United States, Switzerland, United Kingdom Series B, Series A, Series C Biotechnology, Health Care, Therapeutics $5.1M–$107M
Gotzee Ltd
VC Fund
2 Ireland Venture - Series Unknown Medical, Big Data, Health Care $1.2M–$1.9M
SVG Ventures
VC Fund
2 Canada, United States, Australia Non-Equity Assistance, Seed, Pre-Seed AgTech, Agriculture, Farming $16k–$4.7M
Lynett Capital
VC Fund
2 United States, Kenya, Nigeria Seed, Series A, Pre-Seed FinTech, SaaS, Software $230k–$49M
LSP Dementia Fund
VC Fund
2 Belgium, Ireland, United States Series A, Series B, Post-IPO Equity Biotechnology, Health Care, Life Science $39M–$39M
Silicon Valley Bank
VC Fund
2 United States, Canada, United Kingdom Debt Financing, Series B, Series A Software, Health Care, Biotechnology $2M–$105M
Foresite Capital
VC Fund
2 United States, United Kingdom, China Series B, Series C, Series A Biotechnology, Health Care, Medical $17M–$270M
Artis Ventures
VC Fund
2 United States, United Kingdom, India Series A, Series B, Seed Health Care, Biotechnology, Software $2.1M–$127M
Enterprise Equity
VC Fund
2 Ireland, United States, United Kingdom Seed, Series B Software, Information Technology, Health Care $549k–$7.5M
Ascentifi
VC Fund
2 Ireland Seed, Series A, Venture - Series Unknown Health Care, Medical Device, Medical $2.3M–$34M
Infinity Capital
VC Fund
2 United States, Ireland, Canada Series B, Series D, Series A Software, E-Commerce, Semiconductor $4M–$50M
Lightstone Ventures
VC Fund
2 United States, Ireland, India Series A, Series B, Series C Biotechnology, Health Care, Therapeutics $18M–$105M
DeepIE Ventures Management Co.
VC Fund
2 Ireland, France, Switzerland Seed, Series A Manufacturing, AgTech, Software $648k–$5.5M
New Enterprise Associates
VC Fund
1 United States, India, United Kingdom Series A, Series B, Series C Software, Health Care, Biotechnology $5.4M–$103M
Covidien
VC Fund
1 Ireland, United States Series A, Series C Health Care, Biotechnology, Medical Device
Earlybird Venture Capital
VC Fund
1 Germany, United States, United Kingdom Series A, Seed, Series B Software, Information Technology, Health Care
Claret Capital Partners
VC Fund
1 United Kingdom, Germany, United States Debt Financing, Series A Software, Information Technology, Mobile
KBI Biopharma
VC Fund
1 United States, Ireland Seed, Series A, Series D Biotechnology, Life Science, Medical
Carbery Group
VC Fund
1 Ireland Seed Life Science, Biotechnology, Marine Technology
MML Capital Partners
VC Fund
1 United Kingdom, France, United States Private Equity, Series A Manufacturing, Packaging Services, Information Technology
Woodford Investment Management
VC Fund
1 United Kingdom, United States, Ireland Series B, Series A Biotechnology, Health Care, Medical
WxNW
VC Fund
1 Ireland Seed Sales, Consumer, Marketing
ETV Capital SA
VC Fund
1 Ireland, United States, United Kingdom TV, Auctions, Computer
HBM-MedFocus
VC Fund
1 United States, Ireland Series A, Series B, Series C Medical Device, Health Care, Therapeutics $5M–$26M
Access all 289 VC funds in Ireland Biotech startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Enterprise Ireland
VC Fund · Dublin, Dublin, Ireland · 47 investments in Ireland Biotech startups

Enterprise Ireland is the government agency responsible for the development and funding of the indigenous business sector. Their mission is to accelerate the development of companies to achieve strong positions in global markets resulting in increased national and regional prosperity. It was founded in 1998 and headquartered in Dublin, Ireland.

Show more...

Investment focus

  • Industry: Software, Health Care, Information Technology
  • Stage:Seed, Venture - Series Unknown, Grant
  • Geography: Ireland, United States, United Kingdom

Investor stats

  • Total investments: 890
  • Round size: Seed $399k–$3.2M; Grant $16k–$5.5M; Venture - Series Unknown $560k–$8.3M
  • Lead/follow: 29% lead, 71% follow
  • Last fund: May invest from a new fund soon — raised $1.2M in 2021

Portfolio highlights

  • Foodcloud — We connect businesses that have surplus food with Charities and Community Groups that need it.
  • Amethyst Care — Amethyst Care is a startup that creates an AI-powered voice assistant for those with mobility difficulties.
  • Full Health Medical — Full Health Medical patient empowerment tools that improve prevention healthcare are part of the healthcare ecosystem. FHM provides reliable digital innovation, designed by healthcare professionals that are keen to help patients live a healthy life, in response to a national scarcity of healthcare providers, the development of chronic disease, anda lack of transparency at the patient level. People provide lifetime access to preventive care healthcare across screening, diagnostics, education, treatment, and a record of their journey driven technology provides lifetime access to preventative healthcare custom designed at every step screening, diagnostics, education, and action plans that motivate individuals to address risks before they develop health problems.
Show all investments...

SOSV
VC Fund · Princeton, New Jersey, United States · 19 investments in Ireland Biotech startups, 75 in the past 12 months

SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Seed, Convertible Note, Pre-Seed
  • Geography: United States, India, United Kingdom

Investor stats

  • Total investments: 1482
  • Lead/follow: no public data

Portfolio highlights

  • MixRift — MIXRIFT - game developers specialized in Mixed Reality
  • unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
  • Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.
Show all investments...

Western Development Commission
VC Fund · Ballaghaderreen, Roscommon, Ireland · 14 investments in Ireland Biotech startups

Supporting communities to grow, investing in businesses to scale and planning for the future of the western region.

Show more...

Investment focus

  • Industry: Health Care, Medical Device, Biotechnology
  • Stage:Seed, Venture - Series Unknown, Series A
  • Geography: Ireland, United States

Investor stats

  • Total investments: 45
  • Round size: Seed $702k–$3.9M; Series A $2.2M–$11M; Venture - Series Unknown $753k–$17M
  • Lead/follow: 18% lead, 82% follow

Portfolio highlights

  • Ovagen — Ovagen is a biotechnology company that has developed the process of producing germ free (GF) chicken eggs and GF birds in commercial quantities for use primarily in the pharmaceutical industry. Ovagen can also provide a Contract Research Service and has extensive expertise in SPF poultry & rodent housing & husbandry, in specific poultry& rodent research technologies to GMP standards and in avian transgenics.
  • Peroptyx — Peroptyx is a platform that provides managed solutions for machine learning. At Peroptyx, they have assembled and pre-screened a qualified network of data evaluators across the globe. They strategically match ideal evaluators with each product to ensure authentic experiences through consistency and appropriate real-world contexts.
  • Galway Biomedical — Galway Biomedical partners with global medical device companies to bring complex braided devices from early concept through to full-scale production.
Show all investments...

Kernel Capital
VC Fund · Cork, Cork, Ireland · 9 investments in Ireland Biotech startups

Kernel Capital is the independent manager of The Bank of Ireland Kernel Capital Venture Funds, one of the largest and most active sources of equity finance on the island of Ireland. Kernel leverage their extensive network to enable their portfolio companies recruit the highest caliber people, to break into new international markets and to generaterevenues of scale. It is the only investment firm with venture capital Funds dedicated to both jurisdictions on the Island. Kernel have raised over €210M from investors which including their strategic partner Bank of Ireland, Invest NI, Enterprise Ireland, Galway University Foundation, The University of Limerick Foundation, The New York State Common Retirement Fund and undisclosed Family Offices. Consistently delivering strong financial returns for their investors Kernel have led more than 20 substantial trade sales to NASDAQ, NYSE, and LSE listed corporations.

Show more...

Investment focus

  • Industry: Software, Information Technology, Health Care
  • Stage:Seed, Venture - Series Unknown
  • Geography: Ireland, United Kingdom, France

Investor stats

  • Total investments: 96
  • Round size: Seed $531k–$2M; Venture - Series Unknown $1.2M–$12M
  • Lead/follow: 51% lead, 49% follow
  • Last fund: May invest from a new fund soon — raised $40M in 2013

Portfolio highlights

  • Cirdan — Cirdan provides highly reliable, innovative LIS & imaging solutions for the acceleration & enhancement of diagnosis, optimized for pathology & clinical lab.
  • preico — Preico Network empowers Web2 and Web3 developers to create, own, and monetize crypto-native AI models on a decentralized platform
  • Pretto — Pretto is the only truly transparent online real estate price comparator.Pretto accompanies you until the signing of your loan, free of charge and without commitment.
Show all investments...

Irrus Investments
VC Fund · Limerick, Limerick, Ireland · 8 investments in Ireland Biotech startups

Irrus Investments is the leading Irish business angel network with international connections. Fueling Irish innovation in medical devices, software, hardware, digital healthcare and life sciences.

Show more...

Investment focus

  • Industry: Health Care, Medical Device, Biotechnology
  • Stage:Seed, Venture - Series Unknown, Series A
  • Geography: Ireland, Sweden, United States

Investor stats

  • Total investments: 34
  • Round size: Seed $713k–$4.7M; Series A $2.2M–$9.2M; Venture - Series Unknown $1.2M–$24M
  • Lead/follow: 18% lead, 82% follow

Portfolio highlights

  • Novus Diagnostics — Sepsis causing pathogen diagnostics under 15 minutes
  • Deciphex — Deciphex - Transforming Digital Pathology - we are focussed on the development of applications for clinical and veterinary pathology that improve productivity
  • Vertigenius — Vertigenius designs and deploys customized exercises using an easy-to-use clinician portal and even uses a Vertigenius head sensor to consult and manage patients with dizziness and imbalance.
Show all investments...

Atlantic Bridge
VC Fund · Dublin, Dublin, Ireland · 7 investments in Ireland Biotech startups

Atlantic Bridge is a Growth Equity Firm with a Cross Border Value Add strategy. We invest in deep technology companies in Europe and the US. Our team is made up of successful entrepreneurs and senior technology industry executives and we invest in strong ambitious entrepreneurs and management teams that have the passion and drive to scale up andexploit major growth opportunities. We help our portfolio companies expand and grow internationally through our global platform with our team and offices in London, Dublin, Munich, Paris and Palo Alto.Atlantic Bridge brings together a unique team of technology entrepreneurs, experienced managers, finance professionals, and investment experts. The team contains a wealth of international business experience across Europe, the UK and the US. They have worked together in various capacities for the last 30 years, bringing a true partnership approach to their firm and their investments. Its investors include the founders, leading institutional investors, and private investors with a track record of investment in successful technology companies.Atlantic Bridge has developed a unique and differentiated strategy that focuses on specific technology themes and the implementation of the “Atlantic Bridge Model” for scaling companies internationally. The “Bridge Model” accelerates the scale-up of technology companies in Europe and the US. This approach is highly differentiated and has delivered strong performance results to date.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Series A, Series B, Seed
  • Geography: United States, Ireland, United Kingdom

Investor stats

  • Total investments: 154
  • Round size: Seed $1.1M–$7.5M; Series A $5M–$26M; Series B $10M–$62M
  • Lead/follow: 41% lead, 59% follow
  • Last fund: May invest from a new fund soon — raised $97M in 2021

Portfolio highlights

  • GloNav — GloNav develops global positioning system and satellite navigation technologies and products for the wireless handset and mobile consumer electronics device markets. It offers global positioning system radio frequency integrated circuits and single chip assisted-global positioning systems, which are used for low dropout tracking and cellularhandset integration. The company was founded in 2006 and is based in Newport Beach, California. It has locations in the United States, the United Kingdom, Ireland, and Taiwan. As of January 2008, GloNav, Inc. operates as a subsidiary of NXP B.V.
  • Mindgard — Mindgard is the leading provider of AI Red Teaming solutions.
  • Neurobell — NeuroBell develop novel EEG medical devices for early detection and monitoring of neonatal seizures.
Show all investments...

Fountain Healthcare Partners
VC Fund · Dublin, Dublin, Ireland · 7 investments in Ireland Biotech startups

Fountain Healthcare Partners is an Irish based life science venture capital fund. Fountain is exclusively focused on the life science sector. Specific areas of interest to them are: specialty pharma, medical devices, biotechnology and diagnostics. They will deploy the majority of their capital in Europe with a strong focus on Ireland.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series A, Series B, Series C
  • Geography: Ireland, United States, France

Investor stats

  • Total investments: 57
  • Round size: Series A $6.3M–$35M; Series B $5.5M–$68M; Series C $3.3M–$110M
  • Lead/follow: 42% lead, 58% follow
  • Last fund: May invest from a new fund soon — raised $140M in 2019

Portfolio highlights

  • Palyon Medical — Palyon Medical Corporation is a medical device company developing technologies for the treatment of chronic pain, spasticity and other neurological diseases.
  • Neuromod Devices — Neuromod is the global medical device company that developed Lenire, the FDA Approved tinnitus treatment device.
  • Vivasure Medical — Pioneering the Future of Large-Bore Vessel Closure for Arterial and Venous Access. The first and only 100% bio-absorbable, sutureless patch..
Show all investments...

Seroba Life Sciences
VC Fund · Dublin, Dublin, Ireland · 6 investments in Ireland Biotech startups

Seroba is a leading European life sciences venture capital firm focused on value creation through backing winning innovations in biotech and medtech.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series A, Series B
  • Geography: Ireland, United States, United Kingdom

Investor stats

  • Total investments: 48
  • Round size: Series A $5.4M–$33M; Series B $4.6M–$105M
  • Lead/follow: 35% lead, 65% follow
  • Last fund: May invest from a new fund soon — raised $108M in 2017

Portfolio highlights

  • Coave Therapeutics — Coave Therapeutics is active in the field of gene therapies in rare ocular and CNS (Central Nervous System) diseases.
  • Perfuze — Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. Perfuze is located within Galway City in the West of Ireland. The founders have over 30 years combined medtech experience within start-up and large corporations.Perfuze is developing innovative medical technology to treat acute ischemic stroke.Perfuze is developing innovative cathetertechnology to treat acute ischemic stroke. Their technology is intended to provide superior clinical outcomes in shorter procedural times; resulting in safe, cost-effective therapy. Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. The founders have over 30 years combined medtech experience within start-up and large corporations. Perfuze is currently located in the Business Innovation Centre on the campus of the National University of Ireland, Galway, and is in the process of relocating to the IDA Business Park in Dangan, Galway.
  • Azafaros — Azafaros aims at developing therapeutic agents for the treatment of rare metabolic disorders such as lysosomal storage disorders through oral administration of azasugar compounds. These novel, very promising agents were discovered by Professor Hans Aerts at Leiden University and Amsterdam UMC and are exclusively licensed to Azafaros.
Show all investments...

AIB Seed Capital Fund
VC Fund · Dublin, Dublin, Ireland · 6 investments in Ireland Biotech startups

The AIB Seed Capital Fund was established in 2007 to provide venture capital for companies at the seed and early stages of development across a range of sectors throughout the Republic of Ireland. The Fund was established under the Enterprise Ireland Seed and Venture Capital Programme 2007-2012.The Fund has a total of €30m under managementwith AIB and Enterprise Ireland both committing €15m. It is managed by experienced managers with extensive expertise in making seed and early stage investments, adding value and facilitating business success.The Fund managers are empowered to make seed investments of up to approximately €500,000. Furthermore, the Fund has the capacity to make investments in later rounds to support the continued growth of investee companies.The Fund will be managed by Enterprise Equity Venture Capital and the Dublin Business Innovation Centre. This unique partnership brings together extensive regional and investment expertise.Enterprise Equity will evaluate and manage all investments outside the city and county of Dublin, as well as investments that require in excess of €250,000 from the fund within the city and county of Dublin.Dublin Business Innovation Centre (DBIC) will evaluate and manage all investments within the city and county of Dublin when the initial investment amount required from the Fund does not exceed €250,000.

Show more...

Investment focus

  • Industry: Software, Health Care, Medical
  • Stage:Seed, Series A
  • Geography: Ireland, United States, Jersey

Investor stats

  • Total investments: 49
  • Round size: Seed $549k–$3.6M; Series A $1.1M–$8.1M
  • Lead/follow: 18% lead, 82% follow

Portfolio highlights

  • NewsWhip — NewsWhip is the world's most comprehensive content discovery and analytics database. Their suite of products give customers the ability to predict which stories will be important today, and understand how to create successful content over the long term.NewsWhip serves over 500 of the world's leading publishers, brands and agencies,including: Reebok, the Washington Post, Conde Nast, Google, MasterCard, BuzzFeed, Time Inc., and more. NewsWhip Spike is their real-time, predictive content discovery dashboard — offering a one-stop view of what's important across both the web and 5 social networks. Spike is the only tool that discovers stories within 2 minutes of publishing, and predicts their spread across social.NewsWhip Analytics is a database of how audiences have engaged with stories across every social network over the long term. NewsWhip customers use Analytics to benchmark how they stack up against competitors and track engagement trends around events and seasons.
  • Offr — Offr is the new way to buy and sell property, quickly and transparently.
  • Metabolomic Diagnostics — Metabolomic Diagnostics is a deep-tech company specialized in the development of novel biomarker based diagnostic solutions for complex diseases. The company has developed an effective pipeline to firstly identify diagnostic biomarker panels and then translate these panels into clinical assays ready for application in the clinical laboratory.Thispipeline combines the biomarker multiplexing capabilities of Mass Spectrometry, a powerful analytical technology, with the company’s own informatics and statistics solutions to deliver diagnostic innovation. This is reflected in Metabolomic Diagnostics’ strong and versatile IP portfolio of technical innovations and biomarkers.Our VisionMetabolomic Diagnostics’ primary vision is to develop a portfolio of diagnostic solutions which can determine, early in a woman’s pregnancy,her risk of developing major complications much later in her pregnancy and thus enabling personalized care, adapted to each woman’s individual needs. Pregnancy complications like preeclampsia, gestational diabetes, preterm birth, and in-uterine growth restriction, all have the potential to severely impact on the well-being of mother and child.The company’s innovative diagnostic solutions will assist clinicians in re-imagining how these conditions are managed: our novel risk assessment tools are specifically developed in conjunction with prenatal care providers to ensure they make a difference that really matters. This in turn will enable clinicians to improve pregnancy outcomes globally.Our solutions will empower pregnant women: accurate pregnancy risk information will allow a pregnant woman, in partnership with her care provider, to determine what prenatal care is best for her pregnancy.
Show all investments...

HBAN
VC Fund · Dublin, Dublin, Ireland · 6 investments in Ireland Biotech startups

HBAN is dedicated to raising the profile of business angel investment as an asset class on the island of Ireland and to promote the creation of business angel syndicates.

Show more...

Investment focus

  • Industry: Health Care, Software, Medical Device
  • Stage:Seed, Venture - Series Unknown
  • Geography: Ireland, United Kingdom, United States

Investor stats

  • Total investments: 74
  • Round size: Seed $623k–$3.6M; Venture - Series Unknown $375k–$7.3M
  • Lead/follow: 35% lead, 65% follow
  • Last fund: May invest from a new fund soon — raised $11M in 2018

Portfolio highlights

  • Movetru — Movetru a wearable device that aims to reduce injury and enhance rehabilitation.
  • Glitch Ads — GlitchAds intends to democratize advertising by "leveraging" adverts and artificial intelligence.
  • Change by Degrees — Change by degrees supports individuals and organizations in developing sustainable competencies and gaining self-assurance to achieve sustainability goals, expand their businesses, and adhere to legal requirements.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
European Investment Bank
VC Fund · Luxembourg, Luxembourg, Luxembourg · 5 investments in Ireland Biotech startups

The European Investment Bank (EIB) offers lending, borrowing, and treasury services primarily within the European Union. It provides project loans for public and private sectors, loans to banks and intermediaries, structured finance products, guarantees, and securitization instruments for debts. Additionally, EIB offers equity and fund investmentproducts, including infrastructure and environmental funds, as well as venture capital funds. EIB also supports microfinance and risk-sharing finance for research and innovation, and provides technical expertise for sustainable energy projects. Its services include infrastructure advisory, urban development support, guarantees for transport infrastructure, and funding for public-private partnerships and small- to medium-sized enterprises. The bank serves various sectors, including transportation, energy, health, education, and agriculture.

Show more...

Investment focus

  • Industry: Biotechnology, Energy, Health Care
  • Stage:Debt Financing, Post-IPO Debt, Venture - Series Unknown
  • Geography: France, Germany, Spain

Investor stats

  • Total investments: 595
  • Round size: Post-IPO Debt $18M–$587M; Debt Financing $16M–$355M; Venture - Series Unknown $8.7M–$90M
  • Lead/follow: 83% lead, 17% follow

Portfolio highlights

  • VaxThera — VaxThera develops and produces vaccines to prevents and treats diseases.
  • Santander Brasil — Banco Santander in Brazil, its largest division in Latin America and one of the world's most important, accounting for 50%.
  • Reactive Technologies — Reactive Technologies we are committed to enabling a more intelligent use of energy, for the largest and most complex business to the smallest household. Our aim is to develop new technologies that will positively assist the energy industry to deliver cleaner, greener and more affordable energy, through more efficient and effective energymanagement and control. Through our innovative, cloud-based solution for Corporate customers – Tradenergy® – we have begun this process and with our pipeline of ground breaking new technologies we intend to continue.
Show all investments...

Faber
VC Fund · Lisbon, Lisboa, Portugal · 5 investments in Ireland Biotech startups, 7 in the past 12 months

Faber is a Lisbon-based venture capital firm investing in outstanding entrepreneurs who innovate at the intersection of science and technology to drive digital transformation and climate action. The firm combines a specialist focus on deep tech early-stage startups with dedicated funds, investment teams and expert advisors to actively helpfounders build global companies powered by AI/Data, Web3 or Ocean/Climate technologies.Faber’s unique approach in Southern Europe is led by an entrepreneurial management partnership and backed by notable thesis-driven institutions and private investors. Investing since 2013, the firm has been an early investor in hard tech companies such as Unbabel, SWORD Health, Codacy, iLoF or YData.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, SaaS
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Portugal, Germany, United Kingdom

Investor stats

  • Total investments: 100
  • Round size: Seed $595k–$5.2M; Pre-Seed $121k–$3M; Series A $2.5M–$25M
  • Lead/follow: 30% lead, 70% follow
  • Last fund: Likely actively investing — fresh fund, raised $34M in 2024

Portfolio highlights

  • Porelio — Porelio is an environmental technology that provides purification technologies for water and industrial chemicals.
  • Helix Robotics — We are building the first commercial soft manipulator
  • ATMOS Space Cargo — ATMOS Space Cargo develops and manufactures space capsules to return cargo from space, microgravity experiments, Commercial products to entire rocket stages.
Show all investments...

Elkstone Capital Partners
VC Fund · Dublin, Dublin, Ireland · 5 investments in Ireland Biotech startups, 11 in the past 12 months

Elkstone is an investment firm, focusing on entrepreneurs, senior executives, institutional LPs, the venture community, and the Irish diaspora.The objective of the organization is to boost the economic value and overall well-being of the island of Ireland by expanding a network, facilitating deserving investments, and delivering excellentinvestment performance.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Health Care
  • Stage:Seed, Series A, Venture - Series Unknown
  • Geography: Ireland, United Kingdom, United States

Investor stats

  • Total investments: 98
  • Round size: Seed $797k–$5.8M; Series A $5.5M–$18M; Venture - Series Unknown $1.1M–$7.8M
  • Lead/follow: 47% lead, 53% follow
  • Last fund: Likely still investing — raised $108M in 2023

Portfolio highlights

  • Entity — Entity's purpose is shape the future of web gaming by leveraging emerging technologies and maximizing the browser's capabilities. Our next-generation gaming hub, scheduled to arrive in 2027, will be a global place for players to discover, connect, and play together.
  • ZeroRisk.io — https://t.co/Aukldsyhoy is the end-to-end merchant portfolio risk and compliance management system designed to make the payments ecosystem safer.
  • Full Health Medical — Full Health Medical patient empowerment tools that improve prevention healthcare are part of the healthcare ecosystem. FHM provides reliable digital innovation, designed by healthcare professionals that are keen to help patients live a healthy life, in response to a national scarcity of healthcare providers, the development of chronic disease, anda lack of transparency at the patient level. People provide lifetime access to preventive care healthcare across screening, diagnostics, education, treatment, and a record of their journey driven technology provides lifetime access to preventative healthcare custom designed at every step screening, diagnostics, education, and action plans that motivate individuals to address risks before they develop health problems.
Show all investments...

Boole Investment Syndicate
VC Fund · Cork, Cork, Ireland · 4 investments in Ireland Biotech startups

Boole Investment Syndicate invests in new technology start-up's with scalability.

Show more...

Investment focus

  • Industry: Biotechnology, SaaS, Software
  • Stage:Seed, Series A
  • Geography: Ireland, Estonia, United States

Investor stats

  • Total investments: 10
  • Round size: Seed $623k–$2.2M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Ovagen — Ovagen is a biotechnology company that has developed the process of producing germ free (GF) chicken eggs and GF birds in commercial quantities for use primarily in the pharmaceutical industry. Ovagen can also provide a Contract Research Service and has extensive expertise in SPF poultry & rodent housing & husbandry, in specific poultry& rodent research technologies to GMP standards and in avian transgenics.
  • eID easy — One integration - access a worldwide network of QTSPs & CAs, for eSignatures, eID authentication & eSealing. Ensure full compliance with regulations.
  • ArrayPatch — Revolutionising drug delivery with painless microneedle patch technology. Backed by prestigious funding and award-winning innovation.
Show all investments...

Atlantic Bridge University Fund
VC Fund · Dublin, Dublin, Ireland · 4 investments in Ireland Biotech startups

We invest in entrepreneurs with the ambition to create world-class companies of scale.

Show more...

Investment focus

  • Industry: Health Care, Medical Device, Big Data
  • Stage:Seed, Series A, Series B
  • Geography: Ireland, United States

Investor stats

  • Total investments: 33
  • Round size: Seed $859k–$4.2M; Series A $3.4M–$34M; Series B $16M–$80M
  • Lead/follow: 55% lead, 45% follow

Portfolio highlights

  • CroíValve — CroíValve is a developed a safe, effective, easy to use, percutaneous solution for treating all patients with severe Tricuspid Regurgitation
  • PlasmaBound — PlasmaBound provides a step-change technology, termed Controlled Plasma Ablation (CPA), which facilitates the structural adhesive joining of lightweight materials, namely carbon and glass fibre reinforced composites. CPA technology will accelerate the use of these lightweight composite materials into multi-material structural assemblies, byenabling reliable adhesive joining which is stronger than the composite structures themselves.
  • ProVerum Medical — The ProVee stent from Proverum Medical uses 3-D geometry which mirrors and engages with the anatomy of the prostate. The system alleviates Lower Urinary Tract Symptoms (LUTS) by opening the prostatic urethra, applying radial force to the prostatic lobes.
Show all investments...

HBAN Medtech Syndicate
VC Fund · 4 investments in Ireland Biotech startups

HBAN Medtech Syndicate

Show more...

Investment focus

  • Industry: Medical Device, Medical, Health Care
  • Stage:Seed, Series B
  • Geography: Ireland

Investor stats

  • Total investments: 13
  • Round size: Seed $1.3M–$11M
  • Lead/follow: 15% lead, 85% follow

Portfolio highlights

  • FeelTect — FeelTect’s technology, Tight Alright, is a pressure sensing, connected-health device for measuring and monitoring sub-bandage pressure during compression therapy, primarily for the millions of people worldwide with venous leg ulcers (VLUs). Compression is a proven therapy for VLUs, however if it’s applied too loose, it’s ineffective, and if it’stoo tight, it’s dangerous.
  • Neurobell — NeuroBell develop novel EEG medical devices for early detection and monitoring of neonatal seizures.
  • SymPhysis Medical — SymPhysis Medical's goal is to develop innovative technologies that treat a range of chronic diseases, putting the patient experience at the forefront of our design solutions to improve quality of life.About SymPhysis MedicalSymPhysis Medical's emergent technology, releaze, is a drainage technology to treat a common complication oflate-stage cancers, malignant pleural effusion (MPE). MPE causes significant shortness of breath and chest pain in up to 15% of patients with cancer.
Show all investments...

SciFounders
VC Fund · San Francisco, California, United States · 3 investments in Ireland Biotech startups

We invest in highly technical startups from idea-stage up to Series A.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, Ireland, United Kingdom

Investor stats

  • Total investments: 14
  • Round size: Seed $3.2M–$5M; Pre-Seed $400k–$400k; Series A $2.5M–$21M
  • Lead/follow: 29% lead, 71% follow
  • Last fund: Likely still investing — raised $2.5M in 2024

Portfolio highlights

  • Olio Labs — Olio Labs utilizes AI for combo therapeutics, optimizing and minimizing side effects through automated discovery of protein interactions.
  • Current Surgical — Surgery Reinvented - Current Surgical targets early-stage solid tumors in areas where traditional surgical techniques fail.
  • Luminate — Luminate Medical is developing LILY, the world's first pain-free and portable solution to prevent hair loss caused by chemotherapy.
Show all investments...

The Yield Lab Europe
VC Fund · Dublin, Dublin, Ireland · 3 investments in Ireland Biotech startups

The Yield Lab Europe is a €55m early stage Agrifood and Ag Tech fund which comprises an accelerator and a larger follow-on fund, investing in high tech companies with the potential to significant disrupt and improve our current systems of global food production, and to improve the environmental sustainability of the industry. The main fund invests€1m each into 10-12 companies over several follow on rounds, with the strongest accelerator companies expected to progress to the main fund. The Yield Lab Europe is also part of a global network of Agrifood Tech funds, with global headquarters in St Louis USA, and sister funds in LATAM and Singapore.

Show more...

Investment focus

  • Industry: AgTech, Agriculture, Biotechnology
  • Stage:Seed, Series A, Venture - Series Unknown
  • Geography: Ireland, France, United Kingdom

Investor stats

  • Total investments: 40
  • Round size: Seed $605k–$2.9M; Series A $2.1M–$10M; Venture - Series Unknown $1.7M–$9.6M
  • Lead/follow: 35% lead, 65% follow
  • Last fund: May invest from a new fund soon — raised $67M in 2021

Portfolio highlights

  • BBLeap — Farming On Plant Level - We are BBLeap and we are going to create a LEAP in Agriculture! Enabling you to spray exactly what you want. No more, no less!
  • BiOceanOr — BiOceanOr harnessed the power of Marine Biology and AI to deliver bio-guided services that optimize fish welfare and fish growth, while supporting aquaculture sustainability standards
  • Marama Labs — Marama Labs is a developer of a novel UV-Vis spectroscopy technology for scientific-analytical instrumentation. It assists customers in identifying and measuring turbid samples' characteristics by using light's spectral properties. It offers an ultra-violet and visible spectrophotometer for measuring absorption, extinction, and scatteringspectra of clear and turbid liquids to help customers keep their samples intact, reduce sample preparation steps, and improve measurement turnaround time.
Show all investments...

ARCH Venture Partners
VC Fund · Chicago, Illinois, United States · 3 investments in Ireland Biotech startups

ARCH Venture Partners provides seed / early stage venture capital for technology firms in information technology, life sciences, and physical sciences

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Series C
  • Geography: United States, China, United Kingdom

Investor stats

  • Total investments: 472
  • Round size: Series A $9.1M–$213M; Series B $15M–$230M; Series C $15M–$167M
  • Lead/follow: 32% lead, 68% follow
  • Last fund: Likely still investing — raised $3B in 2024

Portfolio highlights

  • Synchron — The endovascular brain computer interface.
  • Ramona — At Ramona, we’re creating a high-throughput microscopy toolset to unlock a new perspective on cellular-level research. With a wider field of view and the capacity to capture data synchronously, we see more — and we see it in motion. By providing a new point of view, our technology enables researchers to make more informed decisions, faster.
  • Moonwalk Biosciences — By deeply profiling and targeting the epigenetic code, Moonwalk aims to reprogram cells to their healthy state, fundamentally enabling a new approach to how therapies are discovered and developed.
Show all investments...

HealthCap
VC Fund · Stockholm, Stockholms Lan, Sweden · 3 investments in Ireland Biotech startups

HealthCap, a life science investor and company creator. Our motivation is to find innovative ideas and invest that could impact healthcare and society.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series B, Series A
  • Geography: United States, Sweden, France

Investor stats

  • Total investments: 141
  • Round size: Series A $6M–$73M; Series B $12M–$92M
  • Lead/follow: 26% lead, 74% follow
  • Last fund: Likely still investing — raised $179M in 2024

Portfolio highlights

  • Neobiomics — Neobiomics is a Swedish life-science company that develops nutritional products for preterm infants and neonatal care. Its best-known products include ProPrems® and NeoMega36®.
  • AMRA Medical — AMRA Medical is a digital health company transforming medical research and clinical care using rapid whole-body MRI technology.
  • Ultragenyx Pharmaceutical — Ultragenyx is focused on developing first-ever approved treatments for rare and ultrarare diseases and moving the rare disease community forward.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Google Ventures
VC Fund · Mountain View, California, United States · 3 investments in Ireland Biotech startups

GV supports innovative founders moving the world forward.

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Series A, Series B, Seed
  • Geography: United States, United Kingdom, Israel

Investor stats

  • Total investments: 1508
  • Round size: Seed $1.1M–$16M; Series A $6M–$100M; Series B $15M–$121M
  • Lead/follow: 30% lead, 70% follow
  • Last fund: May invest from a new fund soon — raised $100M in 2014

Portfolio highlights

  • Tennr — Tennr is a custom AI assistant that accelerates research, answers complex questions, and generates custom reports.
  • ngmoco — ngmoco ("Next Generation MObile COmpany") is creating and producing games for the iPhone. CEO Neil Young is a former executive from Electronic Arts, where he oversaw the development of several hit titles. Another EA vet and partner at Kleiner Perkins, Bing Gordon, sits on the board. Kleiner is an investor through its iFund.
  • SolveAI —
Show all investments...

Furthr VC
VC Fund · Dublin, Dublin, Ireland · 3 investments in Ireland Biotech startups

We are a relationship driven early stage VC investor. We invest in and form close partnerships with the founders we back.We make initial investments at Seed to Series A stage in highly ambitious, born global Irish software and medtech companies. We are hands-on and support teams across key strategic areas to accelerate growth.In addition toproviding institutional investment at an early stage, we reserve significant capital for following on in subsequent rounds. We go the journey with founders.

Show more...

Investment focus

  • Industry: Software, Medical Device, Medical
  • Stage:Seed, Venture - Series Unknown
  • Geography: Ireland

Investor stats

  • Total investments: 31
  • Round size: Seed $797k–$6.3M; Venture - Series Unknown $753k–$17M
  • Lead/follow: 39% lead, 61% follow
  • Last fund: May invest from a new fund soon — raised $36M in 2019

Portfolio highlights

  • WrxFlo — WrxFlo deliver real time data insights and software solutions to allow business achieve greater levels of supply chain efficiencies
  • Trustap — Learn how we make buying & selling online safe & secure, every time. Create an account for free today!
  • Neurobell — NeuroBell develop novel EEG medical devices for early detection and monitoring of neonatal seizures.
Show all investments...

Act Venture Capital
VC Fund · Dublin, Dublin, Ireland · 3 investments in Ireland Biotech startups

Technology-focused, investing capital and expertise to fuel growth in the most promising ideas and companies. Raised c.€600m across multiple funds and invest from seed to growth.We look for companies with potentially cutting-edge, category-defining businesses in markets including application software, IT infrastructure, communications, Internetand mobile. We help founders create and scale businesses globally. We work as a small team with diverse strengths accessing a community of over 200 founders. The teams and companies we back scale their investor base as they scale their business execution and ambition. We work closely with them in this process. Over the past 25 years have built a broad network of US and European investors and founders that share our vision and approach.Act is based in Dublin, Ireland.Our most recent funds are supported by the European Investment Fund.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Seed, Series A
  • Geography: Ireland, United States, United Kingdom

Investor stats

  • Total investments: 165
  • Round size: Seed $1M–$5M; Series A $2.3M–$13M
  • Lead/follow: 45% lead, 55% follow
  • Last fund: Likely still investing — raised $146M in 2022

Portfolio highlights

  • Ubotica — AI-powered maritime surveillance and intelligence that predicts risk, tasks satellites and delivers verified insights to protect critical infrastructure and detect dark vessels.
  • Entity — Entity's purpose is shape the future of web gaming by leveraging emerging technologies and maximizing the browser's capabilities. Our next-generation gaming hub, scheduled to arrive in 2027, will be a global place for players to discover, connect, and play together.
  • Fresco — Fresco powers connected cooking experiences for appliance brands, enabling faster launches, lower R&D costs, and continuous innovation.
Show all investments...

Diagnostics Polymers
VC Fund · 3 investments in Ireland Biotech startups

Investment Fund

Show more...

Investment focus

  • Industry: Medical, Big Data, Health Care
  • Stage:Convertible Note, Venture - Series Unknown
  • Geography: Ireland

Investor stats

  • Total investments: 3
  • Round size: Venture - Series Unknown $1.2M–$1.9M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Metabolomic Diagnostics — Metabolomic Diagnostics is a deep-tech company specialized in the development of novel biomarker based diagnostic solutions for complex diseases. The company has developed an effective pipeline to firstly identify diagnostic biomarker panels and then translate these panels into clinical assays ready for application in the clinical laboratory.Thispipeline combines the biomarker multiplexing capabilities of Mass Spectrometry, a powerful analytical technology, with the company’s own informatics and statistics solutions to deliver diagnostic innovation. This is reflected in Metabolomic Diagnostics’ strong and versatile IP portfolio of technical innovations and biomarkers.Our VisionMetabolomic Diagnostics’ primary vision is to develop a portfolio of diagnostic solutions which can determine, early in a woman’s pregnancy,her risk of developing major complications much later in her pregnancy and thus enabling personalized care, adapted to each woman’s individual needs. Pregnancy complications like preeclampsia, gestational diabetes, preterm birth, and in-uterine growth restriction, all have the potential to severely impact on the well-being of mother and child.The company’s innovative diagnostic solutions will assist clinicians in re-imagining how these conditions are managed: our novel risk assessment tools are specifically developed in conjunction with prenatal care providers to ensure they make a difference that really matters. This in turn will enable clinicians to improve pregnancy outcomes globally.Our solutions will empower pregnant women: accurate pregnancy risk information will allow a pregnant woman, in partnership with her care provider, to determine what prenatal care is best for her pregnancy.
Show all investments...

Pareto Holdings
VC Fund · Miami, Florida, United States · 2 investments in Ireland Biotech startups

Building world-changing companies in sunny Miami

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, FinTech
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, United Kingdom, France

Investor stats

  • Total investments: 627
  • Round size: Seed $880k–$7M; Pre-Seed $125k–$3.5M; Series A $5M–$35M
  • Lead/follow: 2% lead, 98% follow

Portfolio highlights

  • Ascenix —
  • Lambda Robotics —
  • Procedural Robotics —
Show all investments...

Gaingels
VC Fund · New York, New York, United States · 2 investments in Ireland Biotech startups, 75 in the past 12 months

Gaingels is a venture investment syndicate in service of the LGBT+ community and its allies, investing in companies with LGBT+ founders and C-suite leaders at all stages of growth, as well as in more established companies resolved on building more inclusive teams, with a global portfolio of 130+ companies and $70M in deployed investment capital todate. The Gaingels network also actively supports its portfolio in identifying and recruiting diverse talent to their C-suite and board leadership teams and fosters a vibrant global community of industry leaders, investors, operators, and entrepreneurs who share a common goal for positive social change through business and successful investments.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Health Care
  • Stage:Seed, Series A, Venture - Series Unknown
  • Geography: United States, Canada, United Kingdom

Investor stats

  • Total investments: 1348
  • Round size: Seed $1M–$8.1M; Series A $5M–$35M; Venture - Series Unknown $69k–$12M
  • Lead/follow: 1% lead, 99% follow
  • Last fund: Likely actively investing — fresh fund, raised $140k in 2026

Portfolio highlights

  • MoneyStack — Financial stress can be an obstacle to mental health recovery. MoneyStack partners with healthcare teams to integrate financial counseling into treatment plans to improve mental health outcomes and support long-term recovery for individuals and families impacted by someone's behavioral health condition.
  • Tiny Health — Tiny Health is the first at-home gut health test for moms and babies 0-3 years. Detect any gut imbalances early on and prevent chronic conditions.
  • Charter Space — Charter is developing a collaborative platform for satellite mission logistics and program management available via web app and API that provides satellite operators with intuitive information architecture to streamline missions and reduce wasted engineering hours so they can get to the launchpad faster.Charter's platform usesdesign-focused UI/UX and automation to reduce friction through intuitive dashboarding, improved information sharing, and optimized compute and data resource efficiency. For satellite companies, ATLAS streamlines processes, automates manual tasks, and provides engineers with communications and information infrastructure to seamlessly interface both across teams and organisations. reduces wasted engineering hours and lead times, and minimizes upfront technical debt, CapEx, and long-run OpEx.In other words, Charter is building a logistics solution that will be to satellite logistics what the graphical user interface was to command-line interfaces.
Show all investments...

Novartis Venture Fund
VC Fund · Basel, Basel-Stadt, Switzerland · 2 investments in Ireland Biotech startups

Learn about the approach the Novartis Venture Fund takes to investing in innovative life science companies developing biotechnology and biopharmaceutical therapeutics that address unmet patient needs.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series B, Series A, Series C
  • Geography: United States, Switzerland, United Kingdom

Investor stats

  • Total investments: 234
  • Round size: Series A $5.1M–$81M; Series B $11M–$107M; Series C $9M–$75M
  • Lead/follow: 25% lead, 75% follow
  • Last fund: May invest from a new fund soon — raised $200M in 2009

Portfolio highlights

  • Kynexis — Kynexis is leading the way in precision medicine, focusing on the treatment of cognitive impairment associated with schizophrenia (CIAS). Explore our innovative approach and our dedication to improving the lives of millions globally.
  • Visiogen — Visiogen, Inc. is an ophthalmic medical device company specializing in the development of new vision alternatives for patients with cataracts, with and without presbyopia. As part of this mission, Visiogen created the Synchrony dual optic accommodating *intraocular lens (IOL)* for use in the surgical treatment of these conditions.The device isdesigned to provide patients with near, intermediate and distance vision in a seamless continuum without the need for glasses or contact lenses. To eliminate lens handling during surgery, the Synchrony dual optic IOL is provided in a pre-loaded injector. This patented technology has been approved in Europe with a CE Mark designation and is currently undergoing clinical trials in the United States.
  • Rein Therapeutics — Rein Therapeutics is advancing a novel pipeline of first-in-class medicines to address unmet medical needs in orphan pulmonary and fibrosis indications.
Show all investments...

Gotzee Ltd
VC Fund · 2 investments in Ireland Biotech startups

Holding Company

Show more...

Investment focus

  • Industry: Medical, Big Data, Health Care
  • Stage:Venture - Series Unknown
  • Geography: Ireland

Investor stats

  • Total investments: 2
  • Round size: Venture - Series Unknown $1.2M–$1.9M
  • Lead/follow: 100% lead, 0% follow

Portfolio highlights

  • Metabolomic Diagnostics — Metabolomic Diagnostics is a deep-tech company specialized in the development of novel biomarker based diagnostic solutions for complex diseases. The company has developed an effective pipeline to firstly identify diagnostic biomarker panels and then translate these panels into clinical assays ready for application in the clinical laboratory.Thispipeline combines the biomarker multiplexing capabilities of Mass Spectrometry, a powerful analytical technology, with the company’s own informatics and statistics solutions to deliver diagnostic innovation. This is reflected in Metabolomic Diagnostics’ strong and versatile IP portfolio of technical innovations and biomarkers.Our VisionMetabolomic Diagnostics’ primary vision is to develop a portfolio of diagnostic solutions which can determine, early in a woman’s pregnancy,her risk of developing major complications much later in her pregnancy and thus enabling personalized care, adapted to each woman’s individual needs. Pregnancy complications like preeclampsia, gestational diabetes, preterm birth, and in-uterine growth restriction, all have the potential to severely impact on the well-being of mother and child.The company’s innovative diagnostic solutions will assist clinicians in re-imagining how these conditions are managed: our novel risk assessment tools are specifically developed in conjunction with prenatal care providers to ensure they make a difference that really matters. This in turn will enable clinicians to improve pregnancy outcomes globally.Our solutions will empower pregnant women: accurate pregnancy risk information will allow a pregnant woman, in partnership with her care provider, to determine what prenatal care is best for her pregnancy.
Show all investments...

SVG Ventures
VC Fund · Los Gatos, California, United States · 2 investments in Ireland Biotech startups

We are a Venture & Innovation Platform Advancing the Food & Agriculture Industries We work with leading corporations, startups, universities, and growers to solve the biggest challenges facing the food and agriculture industries.

Show more...

Investment focus

  • Industry: AgTech, Agriculture, Farming
  • Stage:Non-Equity Assistance, Seed, Pre-Seed
  • Geography: Canada, United States, Australia

Investor stats

  • Total investments: 314
  • Round size: Seed $100k–$4.7M; Pre-Seed $50k–$100k; Non-Equity Assistance $16k–$40k
  • Lead/follow: 64% lead, 36% follow
  • Last fund: Likely still investing — raised $50M in 2022

Portfolio highlights

  • Robigo — Engineering the plant microbiome for a more sustainable food system
  • Plasmaleap — Plasmaleap is a plasma technology company that manufactures and sells zero-emissions chemical reactors designed for industrial and energy applications. The company develops reactor systems that use plasma processes to enable chemical production and transformation without relying on conventional combustion methods. Its technology supports sectorssuch as clean fuels, chemical manufacturing, and materials processing by offering electrified reactor solutions that can be integrated into existing industrial workflows. Plasmaleap designs modular systems that allow operators to deploy plasma reactors for on-site production and conversion of feedstocks using electricity as the primary energy input. The company also provides engineering support and technical integration services to help customers incorporate its reactor technology into commercial operations. Through its plasma-based approach, Plasmaleap focuses on enabling chemical processes that align with decarbonization and emissions reduction objectives across multiple industries.
  • Brilliant Harvest — Brilliant Harvest is the Most Powerful AI Helpdesk For Equipment Dealers.
Show all investments...

Lynett Capital
VC Fund · San Francisco, California, United States · 2 investments in Ireland Biotech startups

Early-stage venture firm backing founders with world-changing potential. Portfolio includes Hadrian, Flutterwave, Onebrief and Long Wall.

Show more...

Investment focus

  • Industry: FinTech, SaaS, Software
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, Kenya, Nigeria

Investor stats

  • Total investments: 30
  • Round size: Seed $230k–$3.1M; Pre-Seed $500k–$2.7M; Series A $2.5M–$49M
  • Lead/follow: 0% lead, 100% follow
  • Last fund: May invest from a new fund soon — last raise in 2018

Portfolio highlights

  • idler — Push the frontier of your model
  • Juxta — Juxta delivers infrastructure-free positioning for people, assets, and robots. Track indoors, outdoors, and GPS-denied environments with the Universal Positioning System, Software SDK, and Asset Tags.
  • Luminate — Luminate Medical is developing LILY, the world's first pain-free and portable solution to prevent hair loss caused by chemotherapy.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
LSP Dementia Fund
VC Fund · 2 investments in Ireland Biotech startups

Providing capital plus strategic, clinical, operational, financial, and commercial support to deliver the added value inventors seek.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Life Science
  • Stage:Series A, Series B, Post-IPO Equity
  • Geography: Belgium, Ireland, United States

Investor stats

  • Total investments: 5
  • Round size: Series A $39M–$39M
  • Lead/follow: 60% lead, 40% follow

Portfolio highlights

  • Aerska — Aerska develops targeted RNA medicines to treat brain diseases. By silencing genes that cause harm, we can preserve the minds and memories of those we love.
  • QurAlis — QurAlis is a operator of a biotechnology company intended to discover and develop potential precision therapeutics for amyotrophic lateral sclerosis (ALS). The company focuses on the link between genetics and disease in ALS and other neurological diseases, enabling doctors to successfully treat ALS .
  • New Amsterdam Pharma — We're advancing a new era of treatment for cardiovascular disease and other lipid-related conditions.
Show all investments...

Silicon Valley Bank
VC Fund · Santa Clara, California, United States · 2 investments in Ireland Biotech startups

Silicon Valley Bank works with technology, life science, cleantech, venture capital, private equity, and premium wine businesses. SVB provides industry knowledge and connections, financing, treasury management, corporate investment, and international banking services to its clients worldwide through 27 U.S. offices and seven internationaloperations. Banking innovative companies and exclusive wineries, Silicon Valley Bank’s diverse financial services, knowledge, global network, and world-class service increase its clients’ probability of success. Forbes Magazine ranks SVB among America’s Best Banks, and Fortune Magazine named SVB one of the Best Companies to Work For in 2012.

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Debt Financing, Series B, Series A
  • Geography: United States, Canada, United Kingdom

Investor stats

  • Total investments: 780
  • Round size: Series A $5.3M–$27M; Series B $6.5M–$45M; Debt Financing $2M–$105M
  • Lead/follow: 41% lead, 59% follow
  • Last fund: May invest from a new fund soon — last raise in 2016

Portfolio highlights

  • JetZero — JetZero develops commercial aircraft centered on an all-wing or blended wing body design that integrates the fuselage and wings into a single structure to improve aerodynamics and reduce fuel use. The company is advancing the Z4 airplane, which targets lower fuel consumption and associated emissions compared with conventional tube-and-wing jets,and is working with industry partners on systems like engines, composites, and potential hydrogen fuel adaptations. JetZero collaborates with aerospace suppliers, research organizations, and regulatory bodies to design, test, and prepare full-scale demonstrators with the aim of advancing certification and entry into service. The company’s work includes aerodynamic simulation, structural engineering, and exploring sustainable fuel solutions to address aviation’s environmental goals.
  • Zogenix — Therapeutic Solutions for CNS Disorders and Rare Diseases
  • Critical Energy — Critical Energy builds modular power plants for geothermal and waste heat recovery, shipped in standard containers and installed in weeks.
Show all investments...

Foresite Capital
VC Fund · San Francisco, California, United States · 2 investments in Ireland Biotech startups, 18 in the past 12 months

We are a multi-stage investment firm, investing in companies that leverage biology and big data to transform healthcare.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series B, Series C, Series A
  • Geography: United States, United Kingdom, China

Investor stats

  • Total investments: 225
  • Round size: Series A $17M–$165M; Series B $24M–$140M; Series C $37M–$270M
  • Lead/follow: 28% lead, 72% follow
  • Last fund: Likely still investing — raised $900M in 2024

Portfolio highlights

  • Thyme Care — Thyme Care is a dedicated team of nurses and care experts offering value-based cancer care to help you through all phases of the cancer experience.
  • Korsana Biosciences — Korsana Biosciences develops THETA-enabled antibody therapies for neurodegenerative diseases. The company focuses on shuttled monoclonal antibodies that cross the blood-brain barrier to reach central nervous system targets. Its lead program, KRSA-028, is an investigational anti-amyloid beta antibody for Alzheimer’s disease that uses a transferrinreceptor-based shuttle and Fc engineering to improve brain delivery and dosing. Korsana is also advancing additional THETA-based programs for undisclosed neurodegenerative indications.
  • Khartis Therapeutics — Khartis is a drug discovery company developing oral therapies for patients with immune-mediated and chronic diseases. The company focuses on discovering and developing drug candidates intended to address chronic conditions and immune-mediated diseases.
Show all investments...

Artis Ventures
VC Fund · San Francisco, California, United States · 2 investments in Ireland Biotech startups

Artis Ventures has spent over a decade backing bold teams who take the hard path, building market-defining companies to re-shape, re-invent, and re-make industries.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Software
  • Stage:Series A, Series B, Seed
  • Geography: United States, United Kingdom, India

Investor stats

  • Total investments: 151
  • Round size: Seed $2.1M–$35M; Series A $5M–$57M; Series B $20M–$127M
  • Lead/follow: 39% lead, 61% follow
  • Last fund: Likely still investing — raised $141M in 2023

Portfolio highlights

  • GenHealth.ai — GenHealth.ai provides healthcare solutions using generative AI trained on encoded medical events. Its product is a generative healthcare AI publicly available. It includes a foundation transformer model (new neural networks with excellent memory), an API, and user applications that can generate and predict future sequences of health events usinghistorical events. Together they can be used to build a large variety of customized applications.
  • Ozlo Sleep — Ozlo Sleep is a science-driven sleep and audio technology company that supports and simplifies sleep rituals for clinical benefits, without the use of medication.
  • Stateless Networks — Performance, Visibility. Simplicity...It's time for a beautiful network. Stateless is transforming network operations for software-centric networking. Tying together deep network understanding with state-of-the-art distributed systems, cloud, data science and gaming expertise, Stateless transforms network visibility, performance andresponse and helps accelerate the transition to modern network platforms, tying together physical and virtual layers. Focused on the enterprise data center, Stateless currently partners with the world’s leading network and infrastructure vendors (including VMware (VMW), Cisco Systems (CSCO), Cumulus Networks and others) to deliver solutions to some of the world’s largest private data center operators. We’re looking for software and networking engineers in Greater Seattle and the Bay Area with expertise in one or more of the following areas: Distributed Systems, Service Oriented Architecture, Complex Event processing, Functional Programming, Virtualization, Network design and deployment, Network programming, Network troubleshooting, configuration and performance tuning and SDN. Bonus points for experience working with cloud infrastructure (AWS, Azure, OpenStack) or low-level systems software (linux kernel, hypervisors, compilers/language runtimes), complex gaming systems or graphics and computational geometry. For more information visit http://www.statelessnetworks.com/ or follow Stateless on Twitter: @statelessntwrks.see
Show all investments...

Enterprise Equity
VC Fund · Dundalk, Louth, Ireland · 2 investments in Ireland Biotech startups

Enterprise Equity (or EEVC) is an excellent for providing capital to early stage and expanding business throughout Ireland.

Show more...

Investment focus

  • Industry: Software, Information Technology, Health Care
  • Stage:Seed, Series B
  • Geography: Ireland, United States, United Kingdom

Investor stats

  • Total investments: 51
  • Round size: Seed $549k–$2.2M; Series B $2.6M–$7.5M
  • Lead/follow: 10% lead, 90% follow

Portfolio highlights

  • Phorest — Join 8000+ spas, barbers, hair, beauty and nail salon owners using the #1 management, scheduling, POS and appointment booking system. Try Phorest now!
  • SurgaColl — SurgaColl Technologies is a medical device company developing novel tissue regeneration products for the surgical treatment of diseases of the bone, cartilage and other human tissue. Based on technology developed at the Tissue Engineering Research Group (TERG) of the Royal College of Surgeons in Ireland (RCSI), headed by Professor Fergal O’Brien,the company aims to become a leader in the field of regenerative medical devices.
  • Metabolomic Diagnostics — Metabolomic Diagnostics is a deep-tech company specialized in the development of novel biomarker based diagnostic solutions for complex diseases. The company has developed an effective pipeline to firstly identify diagnostic biomarker panels and then translate these panels into clinical assays ready for application in the clinical laboratory.Thispipeline combines the biomarker multiplexing capabilities of Mass Spectrometry, a powerful analytical technology, with the company’s own informatics and statistics solutions to deliver diagnostic innovation. This is reflected in Metabolomic Diagnostics’ strong and versatile IP portfolio of technical innovations and biomarkers.Our VisionMetabolomic Diagnostics’ primary vision is to develop a portfolio of diagnostic solutions which can determine, early in a woman’s pregnancy,her risk of developing major complications much later in her pregnancy and thus enabling personalized care, adapted to each woman’s individual needs. Pregnancy complications like preeclampsia, gestational diabetes, preterm birth, and in-uterine growth restriction, all have the potential to severely impact on the well-being of mother and child.The company’s innovative diagnostic solutions will assist clinicians in re-imagining how these conditions are managed: our novel risk assessment tools are specifically developed in conjunction with prenatal care providers to ensure they make a difference that really matters. This in turn will enable clinicians to improve pregnancy outcomes globally.Our solutions will empower pregnant women: accurate pregnancy risk information will allow a pregnant woman, in partnership with her care provider, to determine what prenatal care is best for her pregnancy.
Show all investments...

Ascentifi
VC Fund · Galway, Galway, Ireland · 2 investments in Ireland Biotech startups

Discover start-up investing made simple. Access VC-led rounds, build your portfolio, and unlock growth at Ascentifi

Show more...

Investment focus

  • Industry: Health Care, Medical Device, Medical
  • Stage:Seed, Series A, Venture - Series Unknown
  • Geography: Ireland

Investor stats

  • Total investments: 9
  • Round size: Seed $2.3M–$11M; Series A $9.2M–$34M; Venture - Series Unknown $3M–$3.5M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • CroíValve — CroíValve is a developed a safe, effective, easy to use, percutaneous solution for treating all patients with severe Tricuspid Regurgitation
  • Vertigenius — Vertigenius designs and deploys customized exercises using an easy-to-use clinician portal and even uses a Vertigenius head sensor to consult and manage patients with dizziness and imbalance.
  • X-BOLT Orthapaedics — X-Bolt Trauma Solutions for osteoporotic bone fixation. FDA 510(k) approved. Clinical studies include the WHITE One (n=100) and WHITE Four (n=1,140) randomized control trials.
Show all investments...

Infinity Capital
VC Fund · Menlo Park, California, United States · 2 investments in Ireland Biotech startups

Infinity Capital are hypothesis-driven investors - constantly calibrating ideas through a Silicon Valley/technology network that they've been building for over two decades. Their extensive technology and operating backgrounds, combined with over a dozen years each of successful startup investing, have been essential in buildingcredibility and a reputation that resonates with entrepreneurs.

Show more...

Investment focus

  • Industry: Software, E-Commerce, Semiconductor
  • Stage:Series B, Series D, Series A
  • Geography: United States, Ireland, Canada

Investor stats

  • Total investments: 34
  • Round size: Series A $5.4M–$24M; Series B $9M–$50M; Series D $4M–$17M
  • Lead/follow: 9% lead, 91% follow
  • Last fund: May invest from a new fund soon — raised $2.4M in 2015

Portfolio highlights

  • AltraTech — Next Generation Molecular Detection Discover Altratech Next Generation Molecular Detection Discover Altratech At Altratech, our mission is to enable next generation molecular detection.
  • BioSapien — BioSapien is a pre-clinical biotech company developing novel biodegradable implantable products that deliver active pharmaceutical ingredients (APIs) for oncology indications with reduced systemic side effects. The applications for this technology are currently under investigation for pancreatic cancer and lung cancer. The intended pipeline ofindications is expected to expand into other cancers such as colorectal, breast, and stomach cancers. BioSapien's 3D-printed MediChip delivers FDA-approved toxic high-dose systemic therapies in a localized slow-release biodegradable mesh which is able to target tissues while improving patients' quality of care and life.
  • Core Starters — Core Starters services startups and investors through blockchain-based decentralized services to solve real problems.
Show all investments...

Lightstone Ventures
VC Fund · Menlo Park, California, United States · 2 investments in Ireland Biotech startups

Lightstone Ventures is a global venture capital firm that invests in personalized medicines and targeted therapeutics. Lightstone Ventures was founded in 2012 by the General Partners and other key members of the life science teams of Advanced Technology Ventures (ATV) and Morgenthaler. The firm was formed to capture the upside of investing inbreakthrough life science companies during a time of unique opportunity in space.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Series C
  • Geography: United States, Ireland, India

Investor stats

  • Total investments: 88
  • Round size: Series A $20M–$95M; Series B $18M–$100M; Series C $20M–$105M
  • Lead/follow: 25% lead, 75% follow
  • Last fund: May invest from a new fund soon — raised $375M in 2021

Portfolio highlights

  • Cerevance — Cerevance is a biotechnology company that develops novel therapeutics for neurological diseases, including chronic neurodegenerative conditions such as Alzheimer's disease, Parkinson's disease, frontotemporal dementia, and amyotrophic lateral sclerosis. Using a large and growing repository of over 15,000 human brain tissue samples, thecompany generates an unprecedented level of expression and epigenetic data, enabling the company to identify the most promising targets for the next generation of treatments for CNS disorders.
  • Psivant Therapeutics — PsiThera is advancing programs across multiple targets from the TNF superfamily and beyond, where no oral therapies currently exist.
  • Crystalys Therapeutics — Transforming care for people living with gout.
Show all investments...

DeepIE Ventures Management Co.
VC Fund · 2 investments in Ireland Biotech startups

DeepIE Ventures Management Co. operates as a venture capital firm.

Show more...

Investment focus

  • Industry: Manufacturing, AgTech, Software
  • Stage:Seed, Series A
  • Geography: Ireland, France, Switzerland

Investor stats

  • Total investments: 11
  • Round size: Seed $648k–$5.5M
  • Lead/follow: 9% lead, 91% follow

Portfolio highlights

  • eID easy — One integration - access a worldwide network of QTSPs & CAs, for eSignatures, eID authentication & eSealing. Ensure full compliance with regulations.
  • ArrayPatch — Revolutionising drug delivery with painless microneedle patch technology. Backed by prestigious funding and award-winning innovation.
  • Marama Labs — Marama Labs is a developer of a novel UV-Vis spectroscopy technology for scientific-analytical instrumentation. It assists customers in identifying and measuring turbid samples' characteristics by using light's spectral properties. It offers an ultra-violet and visible spectrophotometer for measuring absorption, extinction, and scatteringspectra of clear and turbid liquids to help customers keep their samples intact, reduce sample preparation steps, and improve measurement turnaround time.
Show all investments...

New Enterprise Associates
VC Fund · Menlo Park, California, United States · 1 investments in Ireland Biotech startups

Foundational partners to ambitious founders at every stage of company-building.

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Series A, Series B, Series C
  • Geography: United States, India, United Kingdom

Investor stats

  • Total investments: 1581
  • Round size: Series A $5.4M–$60M; Series B $10M–$77M; Series C $14M–$103M
  • Lead/follow: 40% lead, 60% follow
  • Last fund: Likely still investing — raised $2.8B in 2022

Portfolio highlights

  • IonQ — Working to build the world's best quantum computers to solve the world's most complex problems
  • Spyglass Ophthalmics — A vision towards a higher quality of life!
  • Xenon Pharmaceuticals — A leading neuroscience company forging new paths for those living with neurological and psychiatric disorders.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Covidien
VC Fund · Dublin, Dublin, Ireland · 1 investments in Ireland Biotech startups

Covidien plc engages in the development, manufacture, and sale of healthcare products for use in clinical and home settings. Segments The company operates its businesses through four segments: Medical Devices includes the development, manufacture and sale of endomechanical instruments, soft tissue repair products, energy devices, oximetry andmonitoring products, airway and ventilation products, vascular devices, SharpSafety products, clinical care products and other medical device products; Imaging Solutions includes the development, manufacture and marketing of radiopharmaceuticals and contrast products; Pharmaceutical Products includes the development, manufacture and distribution of dosage pharmaceuticals and active pharmaceutical ingredients; and Medical Supplies includes the development, manufacture and sale of nursing care products, medical surgical products and original equipment manufacturer products (OEM). The Medical Device segment develops, manufactures and sells an array of products which the company categorizes in the following product groups: - Endomechanical Instrumentsâ includes its laparoscopic instruments and surgical staplers. - Soft Tissue Repair Productsâ includes its sutures, mesh and biosurgery products. - Energy Devicesâ includes its vessel sealing, electrosurgical and ablation products and related capital equipment. Oximetry and Monitoring Productsâ includes its sensors, monitors and temperature management products. Airway and Ventilation Products—includes its airway, ventilator, breathing systems, sleep and inhalation therapy products. Vascular Devicesâ ”includes its compression and vascular therapy products. SharpSafety Productsâ includes its needles, syringes and sharps disposable products. Clinical Care Productsâ includes its urology, enteral feeding and other advanced woundcare products.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical Device
  • Stage:Series A, Series C
  • Geography: Ireland, United States

Investor stats

  • Total investments: 2
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • FIRE1 — FIRE1 and is based in Dublin, Ireland, will focus on developing novel therapeutic devices.
  • AEGEA Medical — CooperSurgical: Advancing women's health & fertility solutions. Empowering clinics with innovative tech for better patient outcomes.
Show all investments...

Earlybird Venture Capital
VC Fund · Berlin, Berlin, Germany · 1 investments in Ireland Biotech startups, 15 in the past 12 months

Founded in 1997, Earlybird invests in all development and growth phases of technology companies. Among the most experienced venture investors in Europe, Earlybird offers its portfolio companies not only financial resources but also strategic support plus access to an international network and capital markets. With EUR 2 billion under management,eight IPOs and 30 trade sales, Earlybird is one of the most established and active venture capital firms in Europe.

Show more...

Investment focus

  • Industry: Software, Information Technology, Health Care
  • Stage:Series A, Seed, Series B
  • Geography: Germany, United States, United Kingdom

Investor stats

  • Total investments: 305
  • Lead/follow: no public data

Portfolio highlights

  • TopK — TopK features native support for both vector search and keyword search in a single, unified system. With its powerful query expression language, TopK enables you to build reliable search applications (semantic search, RAG, multi-modal, you name it) without juggling multiple databases or services. Our unified retrieval engine will evolve tosupport document transformation, query understanding (parse metadata filters from user query), and adaptive ranking (provide more relevant results by sending “relevance feedback” back to TopK) under one roof.
  • Arago — Arago is an AI and computer hardware company developing an energy-efficient AI chip powered by light, and its associated software.
  • Portal Biotech — Portal has created next generation solutions that address the significant opportunities in protein sequencing and metabolomics
Show all investments...

Claret Capital Partners
VC Fund · London, England, United Kingdom · 1 investments in Ireland Biotech startups

Claret Capital provides specialty debt financing to European growth businesses, predominantly in the technology, life sciences and environmental sectors. Typical loan sizes range from €1M-€40M with the flexibility to do larger transactions opportunistically.They look for investment opportunities in high growth business with proven managementteams in need of capital to fuel organic growth, acquisitions, equipment purchases, bridge loans and various forms of recapitalization.

Show more...

Investment focus

  • Industry: Software, Information Technology, Mobile
  • Stage:Debt Financing, Series A
  • Geography: United Kingdom, Germany, United States

Investor stats

  • Total investments: 91
  • Lead/follow: no public data

Portfolio highlights

  • Abivax — Abivax recently presented impressive 9-month interim extension data from studies of ABX464 in ulcerative colitis during an oral presentation at DDW 2019, demonstrating a continued duration of beneficial effect in patients after 11-months of treatment. View the conference presentation, here:
  • Bitwala — Nuri empowers people to manage and grow their wealth through innovative technologies.
  • Cardiac Dimensions — Cardiac Dimensions, Inc. is a medical device company developing novel interventional tools for the treatment of heart failure and the related condition of mitral valve regurgitation. Our product, the Carillon® Mitral Contour System®, is a groundbreaking, non-surgical device developed to treat functional mitral valve regurgitation. Our system uses acatheter based approach to reshape the mitral valve and reduce mitral regurgitation.
Show all investments...

KBI Biopharma
VC Fund · Durham, North Carolina, United States · 1 investments in Ireland Biotech startups

KBI Biopharma Inc. is a global contract development and manufacturing organization (CDMO / CMO) offering Cell Line Development, Process Analytical & Formulation Development, Clinical & Commercial Manufacturing, and more.

Show more...

Investment focus

  • Industry: Biotechnology, Life Science, Medical
  • Stage:Seed, Series A, Series D
  • Geography: United States, Ireland

Investor stats

  • Total investments: 3
  • Lead/follow: no public data

Portfolio highlights

  • Absci — A better, faster path to new medicines. We translate ideas into drugs with an AI-powered approach to biologic drug discovery and cell line development.
  • GlycoSeLect — GlycoSeLect Ltd specialises in the development and production of Recombinant Prokaryotic Lectins (RPLs).
  • Comera Life Sciences — ReForm Biologics is an engineering superior biotherapeutic formulation for fragile patients. Its proprietary technology provides patented, FDA-friendly excipients for a wide range of therapeutic biologics. Using its platforms, drug companies can make life-saving medicines easier to administer, less immunogenic, more stable, and more efficient toproduce. It was founded in 2014 and is based in Woburn, Massachusetts.
Show all investments...

Carbery Group
VC Fund · Cork, Cork, Ireland · 1 investments in Ireland Biotech startups

Pioneering research and expertise in action. Through innovati drive new product innovation that creates value for our.

Show more...

Investment focus

  • Industry: Life Science, Biotechnology, Marine Technology
  • Stage:Seed
  • Geography: Ireland

Investor stats

  • Total investments: 1
  • Lead/follow: no public data

Portfolio highlights

  • Pure Ocean Algae — Pure Ocean Algae is a biotechnology company that integrates value chains from macro-algae and other marine resources. The company has over the winter of 2019/20 deployed its first trial lines of Palmaria palmata to sea, with initial results being extremely positive. It has also taken primary research in tank-based vegetative production andsucceeded in developing a pilot commercial plant that can produce commercial volumes of Palmaria palmata, at levels approaching 100% per week.
Show all investments...

MML Capital Partners
VC Fund · London, England, United Kingdom · 1 investments in Ireland Biotech startups

MML Capital Partners is an independent investment firm, with over twenty years of history, focused on providing capital to businesses for expansion/acquisitions, management-led equity deals, recapitalisations and buy-outs.

Show more...

Investment focus

  • Industry: Manufacturing, Packaging Services, Information Technology
  • Stage:Private Equity, Series A
  • Geography: United Kingdom, France, United States

Investor stats

  • Total investments: 30
  • Lead/follow: no public data

Portfolio highlights

  • RAVL — Step into the future with RAVL and our revolutionary financial service technology solutions. We're not just building tech; we're crafting the future of financial services. Unleashing potential, one innovative solution at a time. Let's strategize, deliver, and repeat excellence together.
  • SCPACK GROUP — SCPACK GROUP is a packaging and containers manufacturing company for wine, cosmetics and more.
  • Ross-shire Engineering — Trusted water technology solutions and products for purifying drinking water, recycling effluent and cleaning water in industrial processes.
Show all investments...

Woodford Investment Management
VC Fund · Oxford, Oxfordshire, United Kingdom · 1 investments in Ireland Biotech startups

Woodford Investment Management is a privately owned investment firm manages equity mutual funds. At Woodford, they don’t want to be just another fund management company. They want to create something different and better for their investors and they feel strongly that existing and potential clients are entitled to understand what they are doingwith their money.As investors, they are active, engaged, long-term, disciplined, diligent and focused. That’s a lot of things to say about their selves but each word is important in helping you to understand how they manage money – they will explain in more detail as they move along.Their investment approach and process are focused on value discovery, not price discovery. They believe that financial markets are inherently inefficient and that, through disciplined and diligent analysis, they can identify investment opportunities where market prices do not reflect long-term fundamental value. By exploiting this pervasive market characteristic, they believe they can create real long-term value for their investors.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series B, Series A
  • Geography: United Kingdom, United States, Ireland

Investor stats

  • Total investments: 63
  • Lead/follow: no public data

Portfolio highlights

  • Revolut — Join 40+ million customers globally using Revolut to send money to 160+ countries, hold up-to 36 currencies in app, spend in 150+ currencies, and manage their money.
  • Atom Bank — Explore our savings accounts, mortgages and business loans in our digital banking app. Compare our savings rates and join the future of secure digital banking. FSCS protected.
  • Evofem Biosciences — Lithera is developing products for aesthetic medicine to address both medical and lifestyle indications. Its lead product is an injectable treatment to achieve local, selective fat tissue reduction (pharmaceutical lipoplasty). Using FDA registered drugs proven safe and effective in other indications, its product targets and stimulates natural fatmetabolism and achieves non-ablative, non-surgical fat tissue reduction in specific locations.
Show all investments...

WxNW
VC Fund · 1 investments in Ireland Biotech startups

WxNW operates as an investment firm.

Show more...

Investment focus

  • Industry: Sales, Consumer, Marketing
  • Stage:Seed
  • Geography: Ireland

Investor stats

  • Total investments: 2
  • Lead/follow: no public data

Portfolio highlights

  • Ovagen — Ovagen is a biotechnology company that has developed the process of producing germ free (GF) chicken eggs and GF birds in commercial quantities for use primarily in the pharmaceutical industry. Ovagen can also provide a Contract Research Service and has extensive expertise in SPF poultry & rodent housing & husbandry, in specific poultry& rodent research technologies to GMP standards and in avian transgenics.
  • UrbanFox — Discover cutting-edge AI data processing solutions tailored to your needs. Elevate your business with innovative technology, personalized service, and a commitment to excellence.
Show all investments...

ETV Capital SA
VC Fund · London, England, United Kingdom · 1 investments in Ireland Biotech startups

ETV is one of Europe's leading providers of debt financing solutions for venture capital backed technology and healthcare businesses. Founded in 1999, ETV has a long and successful track record of investing in technology or intellectual property based companies across Europe and Israel, diversified by industry and development stage. Theyseek to set their selves apart from other venture lenders by being supportive, flexible and responsive to the needs of their customers, and a testament to their approach is the number of serial entrepreneurs, business angels and senior management that have come back to ETV both through the lifecycle of a company’s growth and for their subsequent ventures.

Show more...

Investment focus

  • Industry: TV, Auctions, Computer
  • Geography: Ireland, United States, United Kingdom

Investor stats

  • Total investments: 3
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • 123.TV — German television channel, 123TV organizes cross-media auctions (TV and internet) on consumer products, for a public of all generations. The auction is reversed in the sense that the price fixed in advance to steady decreases over time until the amounts passed.
  • Nallatech — BittWare provides enterprise-class FPGA hardware and integrated systems featuring technology from AMD, Altera, and Achronix. Accelerate your network, storage, and compute solutions with low-risk, production-ready acceleration cards.
  • Stokes Bio — Stokes Bio develops and distributes microfluidic technology to its clients. It was founded in 2005 and is based in Ireland. It was acquired by Life Technologies in 2010.
Show all investments...

HBM-MedFocus
VC Fund · Irvine, California, United States · 1 investments in Ireland Biotech startups

MedFocus is a Private Equity Firm Dedicated to the Discovery and Investment in Emerging Medical Device Technology.

Show more...

Investment focus

  • Industry: Medical Device, Health Care, Therapeutics
  • Stage:Series A, Series B, Series C
  • Geography: United States, Ireland

Investor stats

  • Total investments: 5
  • Round size: Series A $5M–$26M; Series B $17M–$18M
  • Lead/follow: 60% lead, 40% follow

Portfolio highlights

  • Perfuze — Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. Perfuze is located within Galway City in the West of Ireland. The founders have over 30 years combined medtech experience within start-up and large corporations.Perfuze is developing innovative medical technology to treat acute ischemic stroke.Perfuze is developing innovative cathetertechnology to treat acute ischemic stroke. Their technology is intended to provide superior clinical outcomes in shorter procedural times; resulting in safe, cost-effective therapy. Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. The founders have over 30 years combined medtech experience within start-up and large corporations. Perfuze is currently located in the Business Innovation Centre on the campus of the National University of Ireland, Galway, and is in the process of relocating to the IDA Business Park in Dangan, Galway.
  • Shape Memory Medical — Smart polymer. Smart embolization. Smart choice. Reshaping your view of clinical success through the science of smart polymer.
  • Viseon — Experience Viseon's Advanced Digital Visualization CRANIALSPINALExperience Viseon's
Show all investments...

Biotech VC funding in Ireland at a glance

Stats across 326 deals from 289 investors.

289
investors
in Ireland Biotech startups
326
deals
in Ireland Biotech startups
$3.6M
median round
in Ireland Biotech startups
48%
lead investors
lead at least one round
19%
Seed
most common funding stage

Access all 289 VC funds in Ireland Biotech startups.

Open List

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Biotech VC Funds in Ireland investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 289 VC funds investing in Ireland Biotech startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists

Broader lists